A distinct innate immune signature marks progression from mild to severe COVID-19Stéphane Chevrier, Bernd Bodenmiller|Cell Reports Medicine|2020Cited by 142
The Tumor Profiler Study: integrated, multi-omic, functional tumor profiling for clinical decision supportAnja Irmisch, Martina Haberecker, Ruben Casanova et al.|Cancer Cell|2021Cited by 140
Single-cell landscape of innate and acquired drug resistance in acute myeloid leukemiaRebekka Wegmann, Stefanie Engler, Ximena Bonilla et al.|Nature Communications|2024Cited by 25
The Tumor Profiler Study: Integrated, multi-omic, functional tumor profiling for clinical decision supportAnja Irmisch, Mitchell P. Levesque, Ximena Bonilla et al.|medRxiv|2020Cited by 20
Feasibility of multiomics tumor profiling for guiding treatment of melanomaNicola Miglino, Nora C. Toussaint, Alexander Ring et al.|Nature Medicine|2025Cited by 15